• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.

作者信息

Liu S, Edwards D S, Looby R J, Harris A R, Poirier M J, Barrett J A, Heminway S J, Carroll T R

机构信息

Radiopharmaceuticals Division, DuPont Merck Pharmaceutical Company, North Billerica, Massachusetts 01862, USA.

出版信息

Bioconjug Chem. 1996 Jan-Feb;7(1):63-71. doi: 10.1021/bc950069+.

DOI:10.1021/bc950069+
PMID:8741992
Abstract

A series of 99mTc complexes containing a hydrazinonicotinamide-conjugated cyclic IIb/IIIa receptor antagonist, cyclo(D-Val-NMeArg-Gly-Asp-Mamb-(hydrazinonicotinyl-5- (6-aminocaproic acid))), were synthesized in high yield using tricine or other aminocarboxylates as coligands. These 99mTc complexes have the potential to be used as thrombus imaging agents. The radiolabeling of the HYNIC-conjugated cyclic IIb/IIIa peptide (HYNICtide) was carried out by reaction with pertechnetate in the presence of excess tricine and stannous chloride at pH 4-5. The reaction time and temperature depend on the amount of the HYNICtide and pertechnetate used for the radiolabeling. Very high specific activity (> or = 20,000 mCi/mumol) can be achieved for the complex [99mTc(HYNICtide)(tricine)2] without postlabeling purification. The complex [99mTc(HYNICtide)(tricine)2] was found by two reversed phase HPLC methods to exist as multiple species, some of which interconvert, depending on the temperature, reaction time, and pH of the reaction mixture. The presence of these multiple species is most likely due to different bonding modalities of either the hydrazine moiety of the HYNICtide or the two tricine coligands. The complex [99mTc(HYNICtide)(EDDA)] (EDDA = ethylenediamine-N,N'-diacetic acid) was prepared either by reacting the cyclic IIb/IIIa HYNICtide with pertechnetate, excess EDDA, and stannous chloride at pH 4-5 and 75 degrees C for 30 min or by reacting excess EDDA with [99mTc(HYNICtide)(tricine)2]. The complex [99mTc(HYNICtide)(EDDA)] was found to be stable for at least 12 h in the reaction mixture. Three major species were detected in the radio-HPLC chromatograms, presumably due to the more limited number of possible coordination isomers. Similar results were obtained using other polydentate aminocarboxylates (such as HEDTA, N-(2-hydroxyethyl)ethylenediaminetriacetic acid) as coligands. It is clear that the replacement of tricine by other polydentate aminocarboxylates produces 99mTc-HYNICtide complexes with higher stability and fewer coordination isomers.

摘要

相似文献

1
Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.
Bioconjug Chem. 1996 Jan-Feb;7(1):63-71. doi: 10.1021/bc950069+.
2
A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands.一种新型三元配体体系,用于以含亚胺氮杂环作为共配体对肼基烟酰胺修饰的生物活性分子进行99mTc标记。
Bioconjug Chem. 1998 Sep-Oct;9(5):583-95. doi: 10.1021/bc9800116.
3
New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.用于锝放射性药物的新型多功能三元配体系统:水溶性膦和三(羟甲基)甲基甘氨酸作为共配体,用于用99mTc标记肼基烟酰胺修饰的环状糖蛋白IIb/IIIa受体拮抗剂。
Bioconjug Chem. 1997 Mar-Apr;8(2):146-54. doi: 10.1021/bc970002h.
4
Biological evaluation of thrombus imaging agents utilizing water soluble phosphines and tricine as coligands when used to label a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Bioconjug Chem. 1997 Mar-Apr;8(2):155-60. doi: 10.1021/bc970001p.
5
99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.使用乙二胺二乙酸(EDDA)作为共配体对HYNIC偶联的环状RGDfK二聚体和四聚体进行99mTc标记。
Bioconjug Chem. 2008 Mar;19(3):634-42. doi: 10.1021/bc7004208. Epub 2008 Feb 19.
6
99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.99mTc标记以及HYNIC和(Nα-组氨酸)乙酸修饰的[D-谷氨酸1]-小胃泌素的体外和体内评价
Bioconjug Chem. 2004 Jul-Aug;15(4):864-71. doi: 10.1021/bc0300807.
7
Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules.含吡啶的6-肼基烟酰胺衍生物作为用于小分子生物分子99mTc标记的潜在双功能螯合剂。
Bioconjug Chem. 2004 Jul-Aug;15(4):728-37. doi: 10.1021/bc034141c.
8
Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.注射锝-99m标记的肼基烟酰胺衍生化蛋白质后放射性的细胞内代谢命运。
Bioconjug Chem. 1999 May-Jun;10(3):386-94. doi: 10.1021/bc980105f.
9
Technetium Complexes of a Hydrazinonicotinamide-Conjugated Cyclic Peptide and 2-Hydrazinopyridine: Synthesis and Characterization.
Inorg Chem. 1999 Mar 22;38(6):1326-1335. doi: 10.1021/ic980973o.
10
99mTc-labeling of hydrazones of a hydrazinonicotinamide conjugated cyclic peptide.
Bioconjug Chem. 1999 Sep-Oct;10(5):803-7. doi: 10.1021/bc990022e.

引用本文的文献

1
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers.靶向催产素受体治疗乳腺癌:肽示踪剂的新领域。
J Med Chem. 2024 Feb 8;67(3):1625-1640. doi: 10.1021/acs.jmedchem.3c01089. Epub 2024 Jan 18.
2
Preparation and Bioevaluation of Novel Tc-Labeled Complexes with a 2-Nitroimidazole HYNIC Derivative for Imaging Tumor Hypoxia.新型2-硝基咪唑HYNIC衍生物锝标记配合物用于肿瘤乏氧显像的制备及生物学评价
Pharmaceuticals (Basel). 2021 Feb 15;14(2):158. doi: 10.3390/ph14020158.
3
Rhenium and Technetium-oxo Complexes with Thioamide Derivatives of Pyridylhydrazine Bifunctional Chelators Conjugated to the Tumour Targeting Peptides Octreotate and Cyclic-RGDfK.
含硫酰胺基吡啶基联腙双功能螯合剂的铼和锝氧络合物与肿瘤靶向肽奥曲肽和环 RGDFK 偶联。
Inorg Chem. 2017 Aug 21;56(16):9725-9741. doi: 10.1021/acs.inorgchem.7b01247. Epub 2017 Aug 2.
4
Tc-radiolabeled GE11-modified peptide for ovarian tumor targeting.用于卵巢肿瘤靶向的锝标记GE11修饰肽
Daru. 2017 May 2;25(1):13. doi: 10.1186/s40199-017-0179-8.
5
A Tc-tricine-HYNIC-labeled Peptide Targeting the Melanocortin-1 Receptor for Melanoma Imaging.一种用于黑色素瘤成像的靶向促黑素细胞激素-1受体的锝-三甘氨酰胺-六氮杂环三烯庚胺标记肽。
Iran J Pharm Res. 2016 Summer;15(3):349-360.
6
Well-designed bone-seeking radiolabeled compounds for diagnosis and therapy of bone metastases.设计精良的用于骨转移瘤诊断与治疗的亲骨性放射性标记化合物。
Biomed Res Int. 2015;2015:676053. doi: 10.1155/2015/676053. Epub 2015 May 14.
7
Labeling and Biological Evaluation of (99m)Tc-HYNIC-Trastuzumab as a Potential Radiopharmaceutical for In Vivo Evaluation of HER2 Expression in Breast Cancer.(99m)Tc-HYNIC-曲妥珠单抗作为评估乳腺癌HER2表达的潜在放射性药物的标记与生物学评价
World J Nucl Med. 2013 Jan;12(1):27-32. doi: 10.4103/1450-1147.113953.
8
Design and evaluation of new Tc-99m-labeled lactam bridge-cyclized alpha-MSH peptides for melanoma imaging.新型 Tc-99m 标记的内酰胺桥环化α-MSH 肽用于黑色素瘤成像的设计与评价。
Mol Pharm. 2013 Apr 1;10(4):1400-8. doi: 10.1021/mp3006984. Epub 2013 Mar 1.
9
Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT.放射性标记的环肽 RGD 作为 SPECT 成像肿瘤和血栓的放射性示踪剂。
Theranostics. 2011 Jan 18;1:58-82. doi: 10.7150/thno/v01p0058.
10
Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands.含硫醇盐和席夫碱共配体的铼双肼基嘧啶核配合物的合成与结构表征
Inorganica Chim Acta. 2000 Dec 15;310(2):210-216. doi: 10.1016/S0020-1693(00)00287-5.